IP Library Granted Patent US 12,304,883
Granted Patent B2
US 12,304,883 · App. 17/494,303 · Granted May 20, 2025

1,3-fatty diol compounds and derivatives thereof

Inventors: Haibo Wang (San Pablo, CA); Risha Lindig Bond (South San Francisco, CA)
Assignee: Genomatica, Inc.
C07C33/035C07H15/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,304,883
App. No.
17/494,303
Granted
May 20, 2025
Kind
B2
Abstract

The disclosure relates to the field of specialty chemicals. In particular, the disclosure provides novel 1,3-fatty-diol compounds and derivatives thereof which are useful e.g., in the production of personal care products, surfactants, detergents, polymers, paints, coatings, and as emulsifiers, emollients, and thickeners in cosmetics and foods, as industrial solvents and plasticizers, etc.

Claims (42)

1. A compound having a structure according to Formula VI

a stereoisomer thereof, or a pharmaceutical salt thereof, wherein

R 3 and R 4 are independently selected from the group consisting of H, a monosaccharide,

a disaccharide, a trisaccharide, and a polysaccharide, wherein each of the monosaccharide, disaccharide, trisaccharide or polysaccharide is bound via an anomeric carbon to the oxygen at C-1 and/or C-3 in Formula VI;

m is zero, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, or 18;

a chiral center exists at C-3; and

the chiral center at C-3 has an R configuration or an S configuration; and

R 3 and R 4 are not both H.

2. The compound of claim 1 , wherein neither R 3 nor R 4 are H.

3. The compound of claim 1 , wherein the disaccharide, trisaccharide, or polysaccharide comprises a pentose sugar, a hexose sugar, or a mixture thereof.

4. The compound of claim 3 , wherein the disaccharide, trisaccharide, or polysaccharide comprises a hexose sugar selected from allose, altrose, glucose, mannose, gulose, iodose, galactose, talose, and a mixture of any two or more thereof.

5. The compound of claim 1 , wherein the disaccharide, trisaccharide, or polysaccharide comprises a furanose sugar, a pyranose sugar, or a mixture of any two or more thereof.

6. The compound of claim 1 , wherein R 3 and R 4 are different monosaccharides.

7. The compound of claim 1 , wherein R 3 and R 4 are the same monosaccharide.

8. A composition comprising the compound of claim 1 , wherein the composition is a personal care product, a pharmaceutical, a food product, or an agricultural formulation.

9. The composition of claim 8 , further comprising:

a compound according to Formula V

wherein

n is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, or 14;

R 1 and R 2 are independently selected from H, a monosaccharide, a disaccharide, a trisaccharide, and a polysaccharide, wherein each of the monosaccharide, disaccharide, trisaccharide, or polysaccharide is bound at an anomeric carbon;

the double bond is in a (Z) or an (E) configuration;

a chiral center exists at C-3; and

the chiral center at C-3 has an R configuration or an S configuration.

10. The composition of claim 9 , wherein:

one or both of R 1 and R 2 is not H; and

one or both of R 3 and R 4 is not H.

11. The composition of claim 10 , wherein the compound according to Formula V is an alkyl polyglycoside and the compound according to Formula VI is an alkyl polyglycoside.

12. The compound of claim 1 , wherein m is 3, 5, 7, or 9.

13. The compound of claim 1 , wherein the monosaccharide, disaccharide, trisaccharide, or polysaccharide is bound at the anomeric carbon via an α-glycosidic bond or a β-glycosidic bond.

14. The compound of claim 1 , wherein the monosaccharide is a pentose sugar, a hexose sugar, a furanose sugar, or a pyranose sugar.

15. The compound of claim 14 , wherein the monosaccharide is a hexose sugar selected from allose, altrose, glucose, mannose, gulose, iodose, galactose, and talose.

16. The compound of claim 1 , wherein the chiral center at C-3 has an R configuration.

17. The compound of claim 1 , wherein R 3 is glucose.

18. The compound of claim 1 , wherein the compound is an alkyl polyglycoside.

19. The compound of claim 1 , wherein:

the disaccharide, trisaccharide, or polysaccharide comprises an α-glycosidic linkage or a β-glycosidic linkage; or

the trisaccharide or polysaccharide comprises an α-glycosidic linkage, a β-glycosidic linkage, or mixtures thereof.

20. The composition of claim 9 , wherein:

the monosaccharide, disaccharide, trisaccharide, or polysaccharide comprises a pentose sugar or a hexose sugar, or a mixture thereof;

the monosaccharide, disaccharide, trisaccharide, or polysaccharide comprises furanose sugars, pyranose sugars, or a mixture of any two or more thereof;

the monosaccharide, disaccharide, trisaccharide, or polysaccharide comprises allose, altrose, glucose, mannose, gulose, iodose, galactose, talose, furanose, pyranose, or xylose, or a mixture of any two or more thereof; or

R 1 is glucose and R 3 is glucose.

Assignments (6)
SECURITY INTEREST Recorded Feb 10, 2026
From: GENOMATICA, INC.
To: AGAIN BIO APS
Reel/Frame 074708/0001 →
SECURITY INTEREST Recorded Dec 9, 2025
From: GENOMATICA, INC.
To: NOVO HOLDINGS A/S, AS COLLATERAL AGENT
Reel/Frame 073915/0027 →
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2024
From: BOND, RISHA LINDIG
To: GENOMATICA, INC.
Reel/Frame 066451/0586 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2021
From: WANG, HAIBO
To: REG LIFE SCIENCES, LLC
Reel/Frame 058063/0452 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2021
From: REG LIFE SCIENCES, LLC
To: GENOMATICA, INC.
Reel/Frame 058080/0742 →
Continuity (4)
Continuation 16739645 · Jan 10, 2020
Continuation 15705012 · Sep 14, 2017
Provisional Application 62394537 · Sep 14, 2016
Related Publication 20220098133A1 · Mar 31, 2022
References Cited (33)
US 6384243B1 · Brunerie · 2002 [cited by applicant]
US 9163267B2 · Del Cardayre · 2015 [cited by applicant]
US 9353090B2 · Brenneman et al. · 2016 [cited by applicant]
US 9382189B2 · Dubois et al. · 2016 [cited by applicant]
US 20100227835A1 · Christ et al. · 2010 [cited by applicant]
US 20140275506A1 · Littich et al. · 2014 [cited by applicant]
CN 105218603A · 2016 [cited by applicant]
JP 2000514302A · 2000 [cited by applicant]
JP 2007508300A · 2007 [cited by applicant]
WO 2002069707A1 · 2002 [cited by applicant]
WO WO2006011430A1 · 2006 [cited by applicant]
WO WO2016011430A1 · 2016 [cited by applicant]
Sugiyama et al. Agric. Biol. Chem. 1982, 481-485. [cited by examiner]
Masao et at Tetrahedron (2005), 61(21), 5101-5122. [cited by examiner]
Office Action issued in Corresponding Mexican Application No. MX/a/2019/002913 dated Oct. 1, 2020. [cited by applicant]
El-Sukkary, et al., “Synthesis and Characterization of some Alkyl Polyglycosides Surfactants,” J Surfact Deterg 11: 129-137 (2008). [cited by applicant]
Examination Report issued in corresponding Indian Application No. 201917011120 dated Dec. 11, 2020. [cited by applicant]
Extended European Search Report Issued in corresponding European Application No. 20189079.5 dated Dec. 23, 2020. [cited by applicant]
Office Action from corresponding Indonesia Application No. P00201903036 dated Feb. 25, 2021. [cited by applicant]
Donohoe et al., “Osmium-Mediated Oxidative Cyclizations: A Study into the Range of Initiators That Facilitate Cyclization,” Chem. Asian Journal, 2009, pp. 1237-1247 (11 pages). [cited by applicant]
International Search Report issued in International Application No. PCT/US2017/051664 mailed Nov. 2, 2017 (5 pages). [cited by applicant]
Non-Final Rejection in U.S. Appl. No. 15/705,012 dated Jan. 24, 2019. [cited by applicant]
Notice of Allowance in U.S. Appl. No. 15/705,012 dated Oct. 11, 2019. [cited by applicant]
Non-Final Office Action from corresponding U.S. Appl. No. 16/739,645 dated Feb. 3, 2021. [cited by applicant]
Office Action from corresponding Chinese Application No. 201780063821.1 dated Sep. 22, 2021. [cited by applicant]
Gruuttadauria, M., et al., “Stereoselective Synthesis of Tetrahydrofurans and Tetrahydropyrans by Acid-Catalyzed Cyclization of Hydroxy Selenides and Hydroxy Sulfides,” Tetrahedron, 55: 14097-14110 (1999). [cited by applicant]
He Linli et al: “Regioselective and Stereospecific Azidation of 1,2- and 1,3-Diols by Azidotrimethylsilane via a Mitsunobu Reaction”, The Journal of Organic Chemistry, vol. 64, No. 16, Aug. 1, 1999 (Aug. 1, 1999), pp. 6… [cited by applicant]
Sugiyama Shigeo et al: “Biologically active glycosides from Asteroidea. XXIV. Stereochemistry o the four diastereomers of phytosphingosine”, Liebigs Annalen Der Chemie, Verlag Chemie Gmbh. Weinheim, DE, No. 11, Jan. 1, … [cited by applicant]
Buschhaus Christopher et al: “Very-long-chain 1,2- and 1,3-bifunctional compounds from the cuticular wax of Cosmos bipinnatus petals”, Phytochemistry, vol. 91, Jul. 1, 2013 (Jul. 1, 2013), pp. 249-256, XP093057667, Amst… [cited by applicant]
Honma Miho et al: “Termination of the structural confusion between plipastatin A1 and fengycin XI”, Bioorganic & Medicinal Chemistry, vol. 20, No. 12, Jun. 1, 2012 (Jun. 1, 2012), pp. 3793-3798, XP093057670, Amsterdam, … [cited by applicant]
Onuki, H., et al., “Absolute Structure and Total Synthesis of Lipogrammistin-A, a Lipophilic Ichthyotoxin of the Soapfish,” J. Org. Chem., 63: 3925-3932 (1998). [cited by applicant]
Datcheva, V.K., et al., “Asymmetric Hydroxylation with Lipoxygenase: The Role of Group Hydrophobicity on Regioselectivity, ” J. Am. Chem. Soc., 113: 270-274 (1991). [cited by applicant]
Office Action from corresponding JP Application No. 2022-065450 dated May 22, 2023. [cited by applicant]